M E7

Pill imprint M E7 has been identified as Estropipate 0.75 mg.

Estropipate is used in the treatment of oophorectomy; atrophic vaginitis; atrophic urethritis; primary ovarian failure; postmenopausal symptoms (and more), and belongs to the drug class estrogens. Not for use in pregnancy.

Estropipate 0.75 mg is not subject to the Controlled Substances Act.
See also related documents.

Estropipate Images

Imprint:
M E7
Strength:
0.75 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Inactive Ingredients:
lactose anhydrous
silicon dioxide
croscarmellose sodium
D&C Yellow No. 10
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
Drug Class:
Estrogens
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-4551
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
23490-6906 Palmetto State Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Drug DetailsPrint Page

Estropipate 0.75 mg M E7
Advertisement
Search Again

Search by Imprint, Shape or Color

Note: All fields optional. Use the pill finder to identify medications by visual appearance or name.

Imprint:
Color:
Shape:

Search by Drug Name

Drug Name:

Search by National Drug Codes (NDC)

Did you find this page helpful? Yes No

(web2)